Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

B Burford, A Gentry-Maharaj, R Graham, D Allen, J W Pedersen, A S Nudelman, Klas Ola Blixt, E O Fourkala, D Bueti, A Dawnay, J Ford, R Desai, L David, P Trinder, B Acres, T Schwientek, A Gammerman, C A Reis, Lara Patricia Marcos da Silva, H OsórioR Hallett, H H Wandall, U Mandel, M A Hollingsworth, I Jacobs, I Fentiman, H Clausen, J Taylor-Papadimitriou, U Menon, J M Burchell

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

50 Citationer (Scopus)

Abstract

Autoantibodies have been detected in sera before diagnosis of cancer leading to interest in their potential as screening/early detection biomarkers. As we have found autoantibodies to MUC1 glycopeptides to be elevated in early-stage breast cancer patients, in this study we analysed these autoantibodies in large population cohorts of sera taken before cancer diagnosis.
OriginalsprogEngelsk
TidsskriftB J C
Vol/bind108
Udgave nummer10
Sider (fra-til)2045-55
Antal sider11
ISSN0007-0920
DOI
StatusUdgivet - 28 maj 2013

Citationsformater